SK283195B6 - Kreatínpyruváty, spôsob ich výroby a farmaceutický prostriedok - Google Patents

Kreatínpyruváty, spôsob ich výroby a farmaceutický prostriedok Download PDF

Info

Publication number
SK283195B6
SK283195B6 SK1556-98A SK155698A SK283195B6 SK 283195 B6 SK283195 B6 SK 283195B6 SK 155698 A SK155698 A SK 155698A SK 283195 B6 SK283195 B6 SK 283195B6
Authority
SK
Slovakia
Prior art keywords
creatine
pyruvates
pyruvic acid
pyruvate
anion
Prior art date
Application number
SK1556-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK155698A3 (en
Inventor
Ivo Pischel
Stefan Weiss
Original Assignee
Degussa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19653225A external-priority patent/DE19653225A1/de
Application filed by Degussa Ag filed Critical Degussa Ag
Publication of SK155698A3 publication Critical patent/SK155698A3/sk
Publication of SK283195B6 publication Critical patent/SK283195B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C07C59/19—Pyruvic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
SK1556-98A 1996-12-20 1997-12-18 Kreatínpyruváty, spôsob ich výroby a farmaceutický prostriedok SK283195B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19653225A DE19653225A1 (de) 1996-12-20 1996-12-20 Kreatin-pyruvate und Verfahren zu deren Herstellung
US08/893,423 US6166249A (en) 1996-12-20 1997-07-11 Creatine pyruvates
PCT/EP1997/007121 WO1998028263A1 (de) 1996-12-20 1997-12-18 Kreatin-pyruvate und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
SK155698A3 SK155698A3 (en) 1999-05-07
SK283195B6 true SK283195B6 (sk) 2003-03-04

Family

ID=26032506

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1556-98A SK283195B6 (sk) 1996-12-20 1997-12-18 Kreatínpyruváty, spôsob ich výroby a farmaceutický prostriedok

Country Status (23)

Country Link
US (1) US6172111B1 (ja)
EP (1) EP0894083B1 (ja)
JP (1) JP3090960B2 (ja)
CN (1) CN1076343C (ja)
AT (1) ATE186295T1 (ja)
AU (1) AU727524B2 (ja)
BG (1) BG63537B1 (ja)
BR (1) BR9711954A (ja)
CA (1) CA2255665C (ja)
CZ (1) CZ293282B6 (ja)
DE (1) DE59700666D1 (ja)
DK (1) DK0894083T3 (ja)
ES (1) ES2139465T3 (ja)
GR (1) GR3031754T3 (ja)
HK (1) HK1020718A1 (ja)
IL (1) IL127148A (ja)
NO (1) NO311354B1 (ja)
NZ (1) NZ332830A (ja)
PL (1) PL330279A1 (ja)
RU (1) RU2179970C2 (ja)
SK (1) SK283195B6 (ja)
TR (1) TR199900470T2 (ja)
WO (1) WO1998028263A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
DE19929995B4 (de) 1999-06-30 2004-06-03 Skw Trostberg Ag Verwendung von Kreatin und/oder Kreatin-Derivaten zur Behandlung von Befindlichkeitsstörungen bei Frauen
AU6153200A (en) * 1999-06-30 2001-01-22 Skw Trostberg Aktiengesellschaft Use of creatine and/or creatine derivatives for treating feelings of ill-health in women
DE10003835A1 (de) * 2000-01-28 2001-08-16 Sueddeutsche Kalkstickstoff Formulierungen bei Dehydratationszuständen
EP1688139A1 (en) * 2000-09-14 2006-08-09 Board of Regents of the University of Nebraska Creatine ester pronutrient compounds and formulations
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
US6838562B2 (en) * 2003-04-01 2005-01-04 Sal Abraham Process for preparing a creatine heterocyclic acid salt and method of use
DE10355716A1 (de) 2003-11-26 2005-06-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oderKreatininderivaten und organischen Verdickern
DE502005002355D1 (de) 2004-06-09 2008-02-07 Evonik Degussa Gmbh Guanidinoessigsäure als futtermittelzusatz
DE102006031441B4 (de) * 2006-07-05 2011-12-29 Hans Matt Orales Creatin-Supplement, sowie Verfahren zur Herstellung desselben
DE102007004781A1 (de) 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
DE102007030495A1 (de) 2007-06-30 2009-01-15 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der Gedächtnisleistung, der Merkfähigkeit, des Langzeitgedächtnisses und zur Vorbeugung geistiger Ermüdungszustände
DE102007053369A1 (de) 2007-11-09 2009-07-02 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der männlichen Fruchtbarkeit
DE102007062288A1 (de) 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
US20110123654A1 (en) * 2008-06-06 2011-05-26 Ralf Jaeger Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US8466198B2 (en) * 2008-09-02 2013-06-18 Bruce Kneller Compositions comprising creatine salts and methods of use thereof
WO2011090676A1 (en) 2009-12-29 2011-07-28 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
AU2014280235B2 (en) 2013-06-12 2019-10-03 Anabio Technologies Limited A process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
CN111935990A (zh) 2018-03-27 2020-11-13 赢创运营有限公司 胍乙酸和/或肌酸在水产养殖中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1967400A (en) * 1930-03-27 1934-07-24 Schering Kahlbaum Ag Production of guanidino fatty acids
FR4508M (ja) * 1965-05-06 1966-10-17
US4548937A (en) * 1981-04-01 1985-10-22 Montefiore Hospital Method for preventing body fat deposition in mammals
ATE22655T1 (de) * 1982-11-10 1986-10-15 Laevosan Gmbh & Co Kg Infusionsloesungen zur herztherapie.
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
JP3213666B2 (ja) * 1994-02-28 2001-10-02 治彦 末岡 クレアチン飲料の製造方法
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
IT1271687B (it) * 1994-08-04 1997-06-04 Flamma Spa Sali organici idrosolubili della creatina
US5886040A (en) * 1997-06-17 1999-03-23 Amt Labs, Inc. Creatine pyruvate salt with enhanced palatability

Also Published As

Publication number Publication date
HK1020718A1 (en) 2000-05-19
CA2255665A1 (en) 1998-07-02
NO992603D0 (no) 1999-05-31
DE59700666D1 (de) 1999-12-09
CA2255665C (en) 2002-05-14
CZ293282B6 (cs) 2004-03-17
BG63537B1 (bg) 2002-04-30
CN1224416A (zh) 1999-07-28
EP0894083B1 (de) 1999-11-03
NO992603L (no) 1999-05-31
ATE186295T1 (de) 1999-11-15
BR9711954A (pt) 1999-08-24
JP3090960B2 (ja) 2000-09-25
US6172111B1 (en) 2001-01-09
CN1076343C (zh) 2001-12-19
AU727524B2 (en) 2000-12-14
JPH11509560A (ja) 1999-08-24
ES2139465T3 (es) 2000-02-01
DK0894083T3 (da) 2000-04-03
GR3031754T3 (en) 2000-02-29
NO311354B1 (no) 2001-11-19
SK155698A3 (en) 1999-05-07
AU5857698A (en) 1998-07-17
EP0894083A1 (de) 1999-02-03
TR199900470T2 (xx) 1999-06-21
PL330279A1 (en) 1999-05-10
CZ362698A3 (cs) 1999-03-17
WO1998028263A1 (de) 1998-07-02
RU2179970C2 (ru) 2002-02-27
IL127148A (en) 2002-11-10
NZ332830A (en) 2000-04-28
BG102932A (en) 1999-09-30
IL127148A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
SK283195B6 (sk) Kreatínpyruváty, spôsob ich výroby a farmaceutický prostriedok
US6166249A (en) Creatine pyruvates
CH616080A5 (ja)
US6232497B1 (en) Method for producing alkali metal and alkaline earth metal pyruvates
CN109694359B (zh) 一种硝基呋喃代谢产物-呋喃唑酮aoz-d4的合成方法
US7026507B2 (en) Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
US6342631B1 (en) Method of producing calcium pyruvates
AU725505B2 (en) Method for producing calcium pyruvates
US6306837B1 (en) Heavy metal chelating agent for oral administration, its synthesis and its uses in medicine and health protection
RU2006122472A (ru) Амлодипина гентизат и способ его получения
JPS6014026B2 (ja) パンテテイン−ｓ−スルホン酸及びその塩の製造法
PL104763B1 (pl) Sposob wytwarzania nowej postaci krystalicznej soli sodowej kwasu 7-cyjanoacetyloamino-3-acetoksymetylocefem-3-karboksylowego-4
MXPA98010488A (en) Creatine pyruvates and method for their production
RU1838296C (ru) Производные арилсульфокислот, проявляющие гипогликемическую активность
JP2687141B2 (ja) 新規なキトサン化合物、該化合物の製造方法および該化合物を含む保湿剤
KR20000016221A (ko) 크레아틴 피루베이트 및 이의 제조 방법
EP0923932A1 (en) Composition containing antitumor agent
RU2054000C1 (ru) Кетопантенол, обладающий ацетилирующей активностью d-пантотената кальция
SU677266A1 (ru) Литиевые или кальциевые соли фторсодержащих бензойных кислот,про вл ющие противовоспалительное действие
MXPA99011864A (en) Method for producing calcium pyruvates
EP0997453B1 (en) Phenoxyisobutyric acid ammonium salts and pharmaceutical formulations containing them
CZ457499A3 (cs) Způsob výroby vápenatých pyruvátů
JPH0586092A (ja) グルタチオンモノエステル塩およびその製法
DE1011428B (de) Verfahren zur Herstellung von therapeutisch verwertbaren Calciumsalzen von Polyoxyalkylamin-N, N-di-(alkylcarbonsaeuren)
BE733626A (ja)